Call Options

23 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Jul 18, 2023

BUY
$62.68 - $95.05 $50,144 - $76,040
800 Added 400.0%
1,000 $12,000
Q1 2023

May 01, 2023

SELL
$47.19 - $70.77 $179,322 - $268,926
-3,800 Reduced 95.0%
200 $0
Q4 2022

Feb 07, 2023

BUY
$30.35 - $53.15 $75,875 - $132,875
2,500 Added 166.67%
4,000 $4,000
Q3 2022

Oct 25, 2022

SELL
$31.97 - $49.37 $92,713 - $143,173
-2,900 Reduced 65.91%
1,500 $0
Q2 2022

Aug 04, 2022

SELL
$35.61 - $76.23 $1.14 Million - $2.44 Million
-32,000 Reduced 87.91%
4,400 $1,000
Q1 2022

Apr 14, 2022

BUY
$57.56 - $82.54 $276,288 - $396,192
4,800 Added 15.19%
36,400 $27,000
Q4 2021

Jan 18, 2022

BUY
$72.5 - $100.68 $2.19 Million - $3.04 Million
30,200 Added 2157.14%
31,600 $178,000
Q3 2021

Oct 26, 2021

BUY
$90.24 - $124.05 $90,240 - $124,050
1,000 Added 250.0%
1,400 $0
Q1 2021

Apr 26, 2021

SELL
$116.57 - $155.01 $163,198 - $217,014
-1,400 Reduced 77.78%
400 $6,000
Q4 2020

Jan 21, 2021

SELL
$99.61 - $142.12 $129,493 - $184,756
-1,300 Reduced 41.94%
1,800 $77,000
Q3 2020

Oct 27, 2020

SELL
$72.92 - $102.01 $371,892 - $520,251
-5,100 Reduced 62.2%
3,100 $53,000
Q2 2020

Jul 22, 2020

BUY
$55.75 - $92.75 $429,275 - $714,175
7,700 Added 1540.0%
8,200 $5,000
Q1 2020

May 07, 2020

SELL
$37.9 - $104.44 $492,700 - $1.36 Million
-13,000 Reduced 96.3%
500 $1,000
Q4 2019

Feb 06, 2020

SELL
$77.66 - $99.74 $1.5 Million - $1.92 Million
-19,300 Reduced 58.84%
13,500 $58,000
Q3 2019

Oct 28, 2019

BUY
$90.37 - $122.49 $1.12 Million - $1.52 Million
12,400 Added 60.78%
32,800 $58,000
Q2 2019

Aug 09, 2019

BUY
$89.51 - $118.04 $1.37 Million - $1.81 Million
15,300 Added 300.0%
20,400 $253,000
Q1 2019

May 10, 2019

SELL
$61.98 - $96.5 $396,672 - $617,600
-6,400 Reduced 55.65%
5,100 $40,000
Q4 2018

Feb 05, 2019

SELL
$56.04 - $82.66 $666,876 - $983,654
-11,900 Reduced 50.85%
11,500 $191,000
Q3 2018

Nov 07, 2018

BUY
$48.29 - $80.6 $671,231 - $1.12 Million
13,900 Added 146.32%
23,400 $306,000
Q2 2018

Aug 10, 2018

BUY
$37.84 - $69.96 $128,656 - $237,863
3,400 Added 55.74%
9,500 $218,000
Q1 2018

May 11, 2018

SELL
$39.82 - $57.53 $250,866 - $362,439
-6,300 Reduced 50.81%
6,100 $87,000
Q4 2017

Jan 17, 2018

SELL
$46.49 - $60.51 $2.61 Million - $3.4 Million
-56,200 Reduced 81.92%
12,400 $364,000
Q3 2017

Oct 17, 2017

BUY
$37.05 - $47.12 $2.54 Million - $3.23 Million
68,600
68,600 $756,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.1B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.